A few months ago, I [Steve Fuller] was honoured to be invited to speak at this year’s Faculty of Pharmaceutical Medicine Symposium. Sharing the stage with esteemed professionals who are making a real difference in the world of life sciences was both humbling and inspiring. The event was a testament to the power of collaboration and dialogue in addressing the complex challenges faced by our industry.
Here are some of the key highlights that stood out to me:
A day of expertise and connection
Rav Seeruthun masterfully chaired the day, blending professionalism with light-hearted humour to keep the discussions engaging and accessible. His ability to introduce and facilitate each session seamlessly added an invaluable touch to the event.
Dame Sally Davies GCB DBE FFPM (Hon) delivered an impactful keynote on Pharmaceutical Medicine: Meeting the Global Challenges. She brought to light the urgent need to address the antimicrobial resistance and anti-infectives crisis, particularly the looming antibiotic emergency. Dame Sally’s passionate advocacy, including her representation of the UK Government at the UN General Assembly this year, underscored the critical importance of this issue.
Embracing innovation for equity
Professor Chloe Orkin gave a thought-provoking presentation on Embracing Innovation Across Our Specialty. Drawing on her experience conducting hundreds of clinical trials, she highlighted the importance of ensuring that research represents the diverse populations it aims to serve. Chloe’s work focusing on women, racialised minorities, and older adults has set a powerful example of what can be achieved when equity is prioritised. Her belief that, “With uncompromising commitment, it is feasible to conduct studies of new treatments that are representative of the populations they are designed to treat,” resonates deeply as we continue striving for greater inclusivity in our field.
Tangible actions for diversity and equity
I had the privilege of participating in a panel discussion expertly facilitated by Naila Aslam, alongside Chloe Orkin and Viraj Rajadhyaksha. Together, we explored the topic Diversity in the Pipeline and Equity at the Tap. The discussion led to lively roundtable sessions where actionable steps were identified to drive change. Viraj’s poignant photo captured the essence of our conversation - a reminder of the importance of representation and accountability in shaping the future of pharmaceutical medicine.
Learning from the pandemic
The symposium concluded with an insightful presentation from Professor Jonathan Van-Tam, who reflected on his experiences as Deputy Chief Medical Officer of England during the pandemic. His reflections on lessons learned during this challenging period offered a roadmap for strengthening relationships between governments, pharmaceutical companies, and the NHS. It was a powerful reminder of the resilience and adaptability required to navigate crises and create sustainable solutions.
Looking ahead
This year’s Faculty of Pharmaceutical Medicine Symposium was more than just a meeting of minds; it was a call to action. From tackling global health challenges to ensuring diversity and equity in clinical research, the insights shared by the speakers and participants have reinforced the importance of collaboration in advancing the life sciences.
As I reflect on the day, I am inspired by the collective commitment to innovation and progress. It was an honour to contribute to these critical conversations, and I look forward to seeing how the ideas generated at the symposium continue to shape the future of our industry.
If you'd like to learn more about the discussions and initiatives that came out of the symposium, feel free to reach out or explore the incredible work of the speakers on LinkedIn. Let’s continue to embrace innovation, champion equity, and drive meaningful change.